Omar Amirana, a partner at Oxford Biosciences, a life sciences VC firm that manages more than $1 billion in capital, will be pulling up anchor and moving over to Allied Minds, a “a private equity-funded innovation company.”
Allied Minds, which bills itself as “a holding company that creates subsidiary companies and supports them with capital, management, and shared services,” has offices in Boston and Los Angeles. The firm has over $250 million in assets and specializes in developing technology created at universities and research labs.
Amirana, who has been at Oxford since 2005, has served on the boards of a diverse array of companies including his current position on the board of directors at Cardiofocus and Cambridge Endoscopic Devices. Before transitioning to the investment side, Amirana spent several years as the vice president of business development for St. Jude Medical (NYSE:STJ).